Avorn J - Search Results

1

The $2.6 billion pill--methodologic and policy considerations.

Avorn J. Avorn J. N Engl J Med. 2015 May 14;372(20):1877-9. doi: 10.1056/NEJMp1500848. N Engl J Med. 2015. PMID: 25970049 No abstract available.

2

Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.

Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt D, Walker A. Avorn J, et al. Am J Med. 1995 Jul;99(1):48-54. doi: 10.1016/s0002-9343(99)80104-1. Am J Med. 1995. PMID: 7598142

3

Pharmaceutical cost containment with reference-based pricing: time for refinements.

Schneeweiss S, Maclure M, Dormuth C, Avorn J. Schneeweiss S, et al. Among authors: avorn j. CMAJ. 2002 Nov 26;167(11):1250-1. CMAJ. 2002. PMID: 12451080 Free PMC article. No abstract available.

4

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

Fischer MA, Avorn J. Fischer MA, et al. Among authors: avorn j. Health Serv Res. 2003 Aug;38(4):1051-63. doi: 10.1111/1475-6773.00162. Health Serv Res. 2003. PMID: 12968816 Free PMC article.

5

Underuse of osteoporosis medications in elderly patients with fractures.

Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Solomon DH, et al. Among authors: avorn j. Am J Med. 2003 Oct 1;115(5):398-400. doi: 10.1016/s0002-9343(03)00357-7. Am J Med. 2003. PMID: 14553876 No abstract available.

6

Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?

Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Solomon DH, et al. Among authors: avorn j. Am J Med. 2003 Dec 15;115(9):715-20. doi: 10.1016/j.amjmed.2003.08.025. Am J Med. 2003. PMID: 14693324

7

Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

Schneeweiss S, Maclure M, Carleton B, Glynn RJ, Avorn J. Schneeweiss S, et al. Among authors: avorn j. BMJ. 2004 Mar 6;328(7439):560. doi: 10.1136/bmj.38020.698194.F6. Epub 2004 Feb 24. BMJ. 2004. PMID: 14982865 Free PMC article. Clinical Trial.

8

Patterns of bone mineral density testing: current guidelines, testing rates, and interventions.

Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, Solomon DH. Morris CA, et al. Among authors: avorn j. J Gen Intern Med. 2004 Jul;19(7):783-90. doi: 10.1111/j.1525-1497.2004.30240.x. J Gen Intern Med. 2004. PMID: 15209594 Free PMC article. Review.

9

Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.

Fischer MA, Avorn J. Fischer MA, et al. Among authors: avorn j. Pharmacoepidemiol Drug Saf. 2004 Apr;13(4):207-14. doi: 10.1002/pds.872. Pharmacoepidemiol Drug Saf. 2004. PMID: 15255087

10

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Fischer MA, et al. Among authors: avorn j. N Engl J Med. 2004 Nov 18;351(21):2187-94. doi: 10.1056/NEJMsa042770. N Engl J Med. 2004. PMID: 15548779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results